1. Home
  2. Companies
  3. XEN
  4. Material Events

Xenitra (ASX:XEN) — Material Events

ASX:XEN · 14 articles in the last 12 months · 100% assessed

Click a band to jump to that tier

Significant 13 articles Notable 1 article Not Assessed 0 articles
Major ≥90 Significant 75–89 Notable 50–74 Routine <50 Not assessed
Significant Score 75–89
13
Xenitra Locks In A$12 Million OTC Pharmaceutical Deal With KangshengMedium
Xenitra secures A$12 million OTC pharmaceutical procurement deal with Kangsheng in China
27 July 2026 ·Commercial Agreement Announcement ·85
Xenitra Reports $5.18m Loss Amid Strategic Reset and Revenue RecoveryMedium
Xenitra Limited reports strategic turnaround with revenue recovery, cost cuts, and new growth platforms; loss widens to $5.18 million
31 Aug 2026 ·Annual Report and Financial Results ·85
Xenitra Posts 300% Sales Surge in Q3 Backed by $30M Danone DealMedium
Xenitra Q3 Sales Surge 300% to $8.3M; $30M Rockcheck Partnership Secured
16 Apr 2026 ·Quarterly Sales Update ·Unexpected ·85
Xenitra Posts A$0.8 Million Operating Cash Flow as OTC and OPAL Sales Gain TractionMedium
Xenitra reports positive cash flow turnaround and strong growth in OTC and OPAL sales
30 July 2026 ·Quarterly Operational and Appendix 4C Cashflow Report ·85
Xenitra Locks $30M Danone Deal, Boosts B2B Reach with RockcheckMedium
Xenitra Secures $30M Danone Sales Deal and Authorised Supplier Status with Rockcheck
30 Mar 2026 ·Strategic Partnership Announcement ·85
Xenitra launches OPAL Token and Xen Shop to enhance FMCG loyalty in AsiaMedium
Xenitra launches OPAL Token and Xen Shop to revolutionize FMCG loyalty and sales in Asia
7 Apr 2026 ·Product Launch / Corporate Update ·80
Xenitra’s OPAL Tokenised Sales Surpass $1.1 Million with 400+ Partners in Seven WeeksMedium
Xenitra's OPAL Tokenised Product Sales Surpass $1.1M with 400+ Partners in 7 Weeks
4 June 2026 ·Sales Update ·80
Xenitra Secures Exclusive $5M Biomiq Skincare Deal in Greater ChinaMedium
Xenitra secures exclusive 4-year China distribution deal for Biomiq Skincare with $5m minimum sales target
2 June 2026 ·Distribution Agreement Announcement ·75
Xenitra's OPAL Tokenised Sales Surpass $500k in First Month with 130+ DistributorsMedium
Xenitra's OPAL Tokenised Sales Surpass $500k in First Month with 130+ Distributors
14 May 2026 ·Operational Update ·75
Xenitra Expands Healthcare Reach with A$5 Million FSMP Procurement DealMedium
Xenitra signs A$5 million three-year FSMP procurement agreement with Joy Charm
18 Aug 2026 ·Major Contract Announcement ·75
Xenitra Hits $100K Sales Milestone in First Week of OPAL Tokenised EZZ LaunchMedium
Xenitra launches EZZ products on OPAL token ecosystem with $100k sales in first week
21 Apr 2026 ·Product Launch Announcement ·75
Xenitra Raises A$1.5 Million to Boost Higher-Margin Sales Across OTC and Tokenised ChannelsMedium
Xenitra raises A$1.5 million placement to accelerate higher-margin sales growth across OTC, FSMP, and OPAL
24 Aug 2026 ·Capital Raising ·75
Xenitra Acquires Hong Kong OTC Pharmacy to Boost China Market PresenceMedium
Xenitra Limited Acquires Hong Kong Fukang OTC Pharmacy to Expand China OTC Medicine Business
15 Apr 2026 ·Acquisition Announcement ·75
Not Assessed Low Score, or missing data
0

No articles in this tier for the last 12 months.